HRT Financial’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-12,588
| Closed | -$3.88M | – | 2790 |
|
|
2024
Q4 | $3.88M | Buy |
12,588
+2,500
| +25% | +$771K | 0.02% | 395 |
|
|
2024
Q3 | $2.14M | Buy |
+10,088
| New | +$2.14M | 0.01% | 805 |
|
|
2024
Q1 | – | Sell |
-3,716
| Closed | -$859K | – | 2624 |
|
|
2023
Q4 | $859K | Buy |
+3,716
| New | +$859K | 0.01% | 988 |
|
|
2023
Q2 | – | Sell |
-13,270
| Closed | -$3.21M | – | 2722 |
|
|
2023
Q1 | $3.21M | Buy |
13,270
+2,351
| +22% | +$569K | 0.04% | 390 |
|
|
2022
Q4 | $3.17M | Buy |
+10,919
| New | +$3.17M | 0.04% | 385 |
|
|
2022
Q1 | – | Sell |
-9,589
| Closed | -$812K | – | 3243 |
|
|
2021
Q4 | $812K | Buy |
+9,589
| New | +$812K | ﹤0.01% | 1148 |
|
|
2021
Q3 | – | Sell |
-10,759
| Closed | -$1.05M | – | 3304 |
|
|
2021
Q2 | $1.05M | Buy |
+10,759
| New | +$1.05M | 0.01% | 972 |
|
|
2020
Q4 | – | Sell |
-7,019
| Closed | -$833K | – | 2122 |
|
|
2020
Q3 | $833K | Buy |
+7,019
| New | +$833K | 0.02% | 597 |
|
|
2019
Q4 | – | Sell |
-4,217
| Closed | -$363K | – | 1381 |
|
|
2019
Q3 | $363K | Buy |
+4,217
| New | +$363K | 0.02% | 730 |
|